Your browser is no longer supported. Please, upgrade your browser.
Settings
NXTM Nxstage Medical, Inc. daily Stock Chart
NXTM [NASD]
Nxstage Medical, Inc.
Index- P/E- EPS (ttm)-0.08 Insider Own1.80% Shs Outstand66.15M Perf Week-0.36%
Market Cap1.84B Forward P/E259.35 EPS next Y0.11 Insider Trans-10.03% Shs Float64.50M Perf Month-1.67%
Income-5.00M PEG- EPS next Q0.00 Inst Own95.10% Short Float3.67% Perf Quarter20.70%
Sales378.00M P/S4.86 EPS this Y69.40% Inst Trans-1.11% Short Ratio1.57 Perf Half Y5.92%
Book/sh3.29 P/B8.43 EPS next Y320.00% ROA-1.60% Target Price29.88 Perf Year11.90%
Cash/sh0.95 P/C29.23 EPS next 5Y20.00% ROE-2.40% 52W Range20.45 - 30.80 Perf YTD5.88%
Dividend- P/FCF- EPS past 5Y28.50% ROI-2.50% 52W High-9.90% Beta0.07
Dividend %- Quick Ratio2.20 Sales past 5Y11.00% Gross Margin42.20% 52W Low35.70% ATR0.34
Employees3400 Current Ratio3.30 Sales Q/Q4.30% Oper. Margin-1.60% RSI (14)55.76 Volatility1.89% 1.27%
OptionableYes Debt/Eq0.07 EPS Q/Q-18.10% Profit Margin-1.30% Rel Volume0.23 Prev Close27.69
ShortableYes LT Debt/Eq0.06 EarningsAug 09 BMO Payout- Avg Volume1.51M Price27.75
Recom2.90 SMA20-0.46% SMA503.71% SMA2005.87% Volume347,620 Change0.22%
Aug-22-17Downgrade Leerink Partners Outperform → Mkt Perform
Aug-08-17Downgrade Jefferies Buy → Hold
May-04-17Downgrade Northland Capital Outperform → Market Perform
Jun-28-16Upgrade Northland Capital Market Perform → Outperform
Mar-31-16Resumed Piper Jaffray Overweight $23 → $18.50
Dec-11-15Initiated Sterne Agee CRT Buy
May-03-13Reiterated Feltl & Co. Hold $11.50 → $12
Mar-01-13Reiterated Feltl & Co. Hold $13 → $11.50
Dec-04-12Downgrade Northland Securities Outperform → Market Perform
Sep-07-12Initiated Northland Securities Outperform $18
Feb-18-11Reiterated Rodman & Renshaw Mkt Underperform $15 → $18
Dec-03-10Initiated Jefferies Buy $27
Oct-14-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $15
Sep-15-10Initiated Feltl & Co. Buy $19
Jul-26-10Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
May-06-10Reiterated Rodman & Renshaw Mkt Outperform $11 → $14
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $11
Jun-05-09Upgrade William Blair Mkt Perform → Outperform
Aug-06-08Reiterated SMH Capital Buy $8 → $7
Aug-06-08Reiterated Canaccord Adams Hold $7 → $4.75
Sep-11-17 10:09AM  See what the IHS Markit Score report has to say about NxStage Medical Inc. Markit
Sep-10-17 08:45AM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Nxstage Medical, Inc. - NXTM PR Newswire
Sep-07-17 08:05AM  See what the IHS Markit Score report has to say about NxStage Medical Inc. Markit
Aug-29-17 08:47AM  NxStage System One Gets FDA Nod for Solo Home Hemodialysis Zacks
Aug-28-17 08:00AM  NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage® System One PR Newswire
Aug-24-17 11:39AM  NxStage System One Now in Nine of Top Ten U.S. Nephrology Hospitals PR Newswire
Aug-23-17 08:05AM  See what the IHS Markit Score report has to say about NxStage Medical Inc. Markit
Aug-22-17 09:02AM  The Market In 5 Minutes Benzinga
Aug-17-17 08:05AM  See what the IHS Markit Score report has to say about NxStage Medical Inc. Markit
Aug-16-17 02:31PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of NxStage Medical, Inc. to Fresenius Medical Care for $30 Per Share is Fair to Shareholders Business Wire
Aug-15-17 08:05AM  See what the IHS Markit Score report has to say about NxStage Medical Inc. Markit
Aug-14-17 07:28PM  NXSTAGE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NxStage Medical, Inc. PR Newswire
03:22PM  NxStage Medical Partners Dialyze Direct for On-Site Dialysis Zacks
10:19AM  Foreign Stock Roundup: Novo Nordisk, GOL Linhas Beat on Earnings Zacks
08:05AM  See what the IHS Markit Score report has to say about NxStage Medical Inc. Markit
Aug-11-17 09:36PM  SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of NxStage Medical Acquisition - NXTM ACCESSWIRE
08:23PM  NxStage Medical, Inc. Value Analysis (NASDAQ:NXTM) : August 12, 2017 Capital Cube
09:41AM  NxStage Kidney Care and Dialyze Direct to Provide On-Site Dialysis to Skilled Nursing Facility Patients in Ohio PR Newswire
Aug-10-17 05:08PM  NXSTAGE MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout Business Wire
Aug-09-17 09:22AM  Fresenius Medical Inks $2B Deal to Take Over NxStage Medical Zacks
07:40AM  Corporate News Blog - Fresenius Medical Care to Acquire NxStage Medical to Strengthen Its Vertically Integrated Dialysis Business ACCESSWIRE
06:30AM  Investor Network: NxStage Medical, Inc. to Host Earnings Call ACCESSWIRE
Aug-08-17 05:30PM  Rowley Law PLLC is Investigating NxStage Medical, Inc. and its Board of Directors for Potential Breaches of Fiduciary Duty PR Newswire
02:38PM  WeissLaw LLP: NxStage Medical, Inc. Acquisition May Not Be in the Best Interests of NXTM Shareholders PR Newswire
02:12PM  NXSTAGE MEDICAL, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Fresenius Medical Care May be Unfair to Shareholders Business Wire
11:51AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of NxStage Medical, Inc. (NXTM) PR Newswire
09:35AM  Company News For August 08, 2017 Zacks
08:26AM  NxStage Medical, Inc. breached its 50 day moving average in a Bullish Manner : NXTM-US : August 8, 2017 Capital Cube
12:37AM  [$$] Fresenius Unit Buys NxStage Medical in $2 Billion Dialysis Deal The Wall Street Journal
12:00AM  NxStage reports 2Q loss Associated Press
Aug-07-17 09:05PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of NxStage Medical, Inc. - NXTM ACCESSWIRE +28.22%
08:10PM  Dow Scores Ninth Straight Record Close With Tiny Gains, S&P 500 at All-Time High TheStreet.com
05:31PM  Buyout Bid Overshadows NxStage Medical's Losses Motley Fool
04:20PM  Why NxStage Medical, MyoKardia, and Rockwell Collins Jumped Today Motley Fool
03:48PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Commencement of an Investigation Concerning Whether the Sale of NxStage Medical, Inc. to Fresenius Medical Care for $30 Per Share is Fair to Shareholders Business Wire
03:11PM  Fresenius to buy Lawrence-based NxStage Medical for $2B American City Business Journals
03:10PM  Dow Is Back on Track to Close at a Record High as Consumer Staples Lead TheStreet.com
02:32PM  Harwood Feffer LLP Announces Investigation of NxStage Medical, Inc. PR Newswire
12:18PM  NxStage (NXTM) Jumps 28% on $2 Billion Acquisition by FMS Zacks
12:10PM  [$$] Fresenius Medical Care agrees $2bn deal to buy NxStage Financial Times
11:53AM  Why NxStage Medical, Inc. Is Skyrocketing Today Motley Fool
11:33AM  Fresenius Medical banks on home dialysis with $2 bln NxStage acquisition Reuters
11:26AM  [$$] Fresenius/NxStage: dialysis analysis Financial Times
10:41AM  Energy Losses Put Dow's Record-Breaking Streak in Jeopardy TheStreet.com
08:39AM  Stock Futures Rise as Dow Shoots for Its Ninth Straight Day of Records TheStreet.com
08:27AM  Reuters Business News Schedule at 1230 GMT/8.30AM ET Reuters
08:06AM  [$$] Fresenius Unit Buys NxStage Medical in $2 Billion Dialysis Deal The Wall Street Journal
07:48AM  NxStage Medical Acquired by Fresenius for $2 Billion TheStreet.com
07:25AM  Dow on track for 9th record in a row MarketWatch
06:29AM  Fresenius Pays an Arm, and Maybe a Leg Bloomberg
05:52AM  Dow industrials shape up for record No.9 MarketWatch
05:02AM  NxStage reports 2Q loss Associated Press
02:14AM  NxStage Reports Second Quarter Financial Results PR Newswire
01:41AM  Fresenius Medical Care to Acquire NxStage Medical, Inc. to Strengthen Its Vertically Integrated Dialysis Business Business Wire
01:38AM  Germany's FMC to buy U.S. home dialysis firm NxStage for $2 bln Reuters
Aug-04-17 09:47AM  Over One Hundred NxStage Patients Celebrate Ten-Year Anniversary on Home Hemodialysis with the System One PR Newswire
Jul-28-17 09:38AM  NxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : July 28, 2017 Capital Cube
Jul-13-17 04:20PM  ETFs with exposure to NxStage Medical, Inc. : July 13, 2017 Capital Cube
Jul-10-17 04:45PM  NxStage® to Report Second Quarter 2017 Financial Results PR Newswire
Jun-28-17 08:19AM  NxStage Medical, Inc. breached its 50 day moving average in a Bullish Manner : NXTM-US : June 28, 2017 Capital Cube
Jun-26-17 04:35PM  ETFs with exposure to NxStage Medical, Inc. : June 26, 2017 Capital Cube
Jun-25-17 10:27AM  3 Stocks That Could Be Life-Changers Motley Fool
Jun-16-17 04:07PM  ETFs with exposure to NxStage Medical, Inc. : June 16, 2017 Capital Cube
Jun-15-17 08:00AM  NxStage Launches 3rd Annual Nurse Hero Contest to Celebrate Home Hemodialysis Nurses PR Newswire
Jun-14-17 09:48AM  NxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
Jun-02-17 08:00AM  New Data from KIHDNEy Cohort Shows Improved Biochemical Outcomes and Broad Range Patient Suitability with More Frequent Hemodialysis Using the NxStage System One PR Newswire +5.09%
May-25-17 08:00AM  NxStage Announces Second Quarter 2017 Investor Conference Schedule PR Newswire
May-14-17 09:15PM  Edited Transcript of NXTM earnings conference call or presentation 9-May-17 1:00pm GMT Thomson Reuters StreetEvents
May-10-17 12:44PM  NxStage Medical Announces FDA Clearance for its New System One Hemodialysis System PR Newswire
May-09-17 01:02PM  Why NxStage Medical, Inc. Got Hammered Today Motley Fool -15.01%
10:15AM  NxStage Medical Cuts Its Home Sales Outlook Motley Fool
08:45AM  Investor Network: NxStage Medical, Inc. to Host Earnings Call Accesswire
08:29AM  NxStage reports 1Q loss Associated Press
08:16AM  NxStage Reports First Quarter Financial Results PR Newswire
May-05-17 04:26PM  4 Medical Stocks That Could Be Big Winners Next Week Benzinga
May-04-17 08:54AM  NxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : May 4, 2017 Capital Cube
May-03-17 04:55PM  Why Nxstage Medical, Inc. Slumped Today Motley Fool -10.76%
Apr-24-17 03:41PM  NxStage Medical, Inc. Value Analysis (NASDAQ:NXTM) : April 24, 2017 Capital Cube
Apr-21-17 08:47AM  NxStage Medical, Inc. breached its 50 day moving average in a Bullish Manner : NXTM-US : April 21, 2017 Capital Cube
Apr-06-17 08:00AM  NxStage® to Report First Quarter 2017 Financial Results PR Newswire
Mar-21-17 08:17AM  NxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : March 21, 2017 Capital Cube
Mar-10-17 07:53AM  NxStage Medical, Inc. breached its 50 day moving average in a Bullish Manner : NXTM-US : March 10, 2017 Capital Cube
Mar-09-17 08:00AM  New Data Shows Significant Potential Cost Savings with On-Site Hemodialysis in Skilled Nursing Facilities PR Newswire
Mar-04-17 01:04PM  NXSTAGE MEDICAL, INC. Financials
Mar-03-17 07:54AM  NxStage Medical: NxGen Hemodialysis System Now CE Marked Zacks
Mar-02-17 01:43PM  NxStage Medical Announces CE Mark for its NxGen Hemodialysis System PR Newswire
12:55PM  NxStage Medical, Inc. :NXTM-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017 Capital Cube
Mar-01-17 10:45AM  NxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 1, 2017
Feb-28-17 06:37PM  NXSTAGE MEDICAL, INC. Files SEC form 10-K, Annual Report
02:48PM  Edited Transcript of NXTM earnings conference call or presentation 28-Feb-17 2:00pm GMT Thomson Reuters StreetEvents
09:40AM  2017 Should Bring NxStage Medical a Profit Motley Fool
08:27AM  NxStage reports 4Q loss Associated Press
08:02AM  NxStage Reports Fourth Quarter and Full-Year 2016 Financial Results PR Newswire
07:07AM  Q4 2016 NxStage Medical Inc Earnings Release - Before Market Open
Feb-16-17 08:41AM  NxStage Announces First Quarter 2017 Investor Conference Schedule PR Newswire
Feb-03-17 08:00AM  NxStage Announces Appointment of Chief Medical Officer PR Newswire
Jan-25-17 08:49AM  NxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : January 25, 2017
Jan-19-17 01:38PM  ETFs with exposure to NxStage Medical, Inc. : January 19, 2017 -6.10%
Jan-16-17 12:00PM  NxStage® to Report Fourth Quarter and Full Year 2016 Financial Results PR Newswire
Jan-04-17 08:39AM  Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay
NxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. The company operates through three segments: System One, In-Center, and Services. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment, as well as sells disposable products in the home and critical care market for the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting and in the critical care market for the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment engages in the sale of blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers, and needles for apheresis. The Services segment offers dialysis services to patients at NxStage Kidney Care dialysis centers. NxStage Medical, Inc. markets its products through direct sales and distributors to hospitals and dialysis clinics in the United States and internationally. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Swan Winifred LSVP and General CounselSep 20Option Exercise11.033,00033,09015,770Sep 21 07:14 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeSep 20Option Exercise14.054,30060,41528,721Sep 21 07:07 PM
Swan Winifred LSVP and General CounselSep 20Sale27.273,50095,44512,270Sep 21 07:14 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeSep 20Sale27.274,300117,26124,421Sep 21 07:07 PM
Mixer Jean KDirectorSep 12Option Exercise13.6018,196247,46624,901Sep 13 05:07 PM
Turk Joseph E JrPresidentSep 05Sale27.951,00027,95073,903Sep 05 04:07 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeAug 21Option Exercise14.054,30060,41528,721Aug 23 04:14 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeAug 21Sale29.224,300125,64624,421Aug 23 04:14 PM
Swan Winifred LSVP and General CounselAug 15Option Exercise11.033,00033,09016,270Aug 15 04:35 PM
Swan Winifred LSVP and General CounselAug 15Sale29.213,500102,23512,770Aug 15 04:35 PM
Turk Joseph E JrPresidentAug 10Sale29.261,00029,26074,903Aug 10 04:14 PM
Turk Joseph E JrPresidentAug 07Option Exercise14.4124,000345,78699,903Aug 08 06:35 PM
Turk Joseph E JrPresidentAug 07Sale29.6424,000711,30075,903Aug 08 06:35 PM
Turk Joseph E JrPresidentAug 03Option Exercise11.037,00077,21082,903Aug 04 08:00 PM
Turk Joseph E JrPresidentAug 03Sale22.987,000160,86075,903Aug 04 08:00 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeJul 20Option Exercise14.054,30060,41528,721Jul 21 06:07 PM
Swan Winifred LSVP and General CounselJul 20Option Exercise11.033,00033,09016,770Jul 21 06:28 PM
Swan Winifred LSVP and General CounselJul 20Sale24.163,50084,56013,270Jul 21 06:28 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeJul 20Sale24.164,300103,88824,421Jul 21 06:07 PM
Turk Joseph E JrPresidentJul 05Sale25.191,00025,19075,903Jul 07 05:35 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeJun 20Option Exercise14.054,30060,41529,637Jun 21 06:49 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeJun 20Sale23.294,300100,14725,337Jun 21 06:49 PM
Swan Winifred LSVP and General CounselJun 15Option Exercise11.033,00033,09017,270Jun 16 06:07 PM
Swan Winifred LSVP and General CounselJun 15Sale23.143,50080,99013,770Jun 16 06:07 PM
Turk Joseph E JrPresidentJun 14Sale23.741,00023,74075,903Jul 07 05:28 PM
Turk Joseph E JrPresidentJun 08Option Exercise18.592,25041,82880,153Jun 12 04:35 PM
Turk Joseph E JrPresidentJun 08Sale23.592,25053,07877,903Jun 12 04:35 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeMay 22Option Exercise14.054,30060,41529,637May 23 04:21 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeMay 22Sale21.364,30091,84825,337May 23 04:21 PM
Swan Winifred LSVP and General CounselMay 15Option Exercise11.033,00033,09017,770May 15 05:21 PM
Swan Winifred LSVP and General CounselMay 15Sale21.943,50076,79014,270May 15 05:21 PM
Turk Joseph E JrPresidentMay 10Option Exercise18.592504,64878,153May 11 05:56 PM
Turk Joseph E JrPresidentMay 10Sale23.592505,89877,903May 11 05:56 PM
Turk Joseph E JrPresidentMay 03Sale29.951,00029,95077,903May 04 05:14 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeApr 20Option Exercise14.054,30060,41529,637Apr 20 04:42 PM
Swan Winifred LSVP and General CounselApr 20Option Exercise11.033,00033,09018,270Apr 20 04:56 PM
Donigan Heyward RDirectorApr 20Option Exercise21.733,58277,8373,582May 26 03:21 PM
Burbank Jeffrey HChief Executive OfficerApr 20Sale27.283,00081,840939,086Apr 21 04:07 PM
Swan Winifred LSVP and General CounselApr 20Sale27.283,50095,48014,770Apr 20 04:56 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeApr 20Sale27.284,300117,30425,337Apr 20 04:42 PM
Burbank Jeffrey HChief Executive OfficerApr 19Sale26.653,00079,950942,086Apr 20 04:35 PM
Turk Joseph E JrPresidentApr 13Sale26.101,00026,10078,903Apr 14 05:35 PM
Brown Robert S.President, NxStage Kidney CareApr 03Option Exercise15.5811,917185,66728,003Apr 04 05:14 PM
Brown Robert S.President, NxStage Kidney CareApr 03Sale26.6014,397382,96013,606Apr 04 05:14 PM
Burbank Jeffrey HChief Executive OfficerMar 22Sale27.423,00082,260945,086Mar 23 04:35 PM
Burbank Jeffrey HChief Executive OfficerMar 21Sale27.723,00083,160948,086Mar 22 05:42 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeMar 20Option Exercise14.054,30060,41529,637Mar 22 05:56 PM
Swan Winifred LSVP and General CounselMar 20Option Exercise18.5915,223282,99630,993Mar 22 06:07 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeMar 20Sale27.664,300118,93825,337Mar 22 05:56 PM
Swan Winifred LSVP and General CounselMar 20Sale27.6615,723434,89815,270Mar 22 06:07 PM
MOORE CRAIG WDirectorMar 16Sale27.931,00027,93094,943Mar 16 05:21 PM
REID PERPERDirectorMar 10Option Exercise14.9915,272228,927135,851Mar 13 07:21 PM
Turk Joseph E JrPresidentMar 08Sale27.531,00027,53079,903Mar 08 06:42 PM
Brown Robert S.President, NxStage Kidney CareMar 07Option Exercise16.6620,000333,20036,086Mar 07 05:42 PM
Brown Robert S.President, NxStage Kidney CareMar 07Sale27.7520,000555,00016,086Mar 07 05:42 PM
Brown Robert S.President, NxStage Kidney CareMar 06Sale28.016,390178,98416,086Mar 06 06:56 PM
Brown Robert S.President, NxStage Kidney CareMar 03Option Exercise0.009,747027,062Mar 06 06:56 PM
Swan Winifred LSVP and General CounselMar 03Option Exercise0.007,919018,392Mar 06 06:49 PM
Turk Joseph E JrPresidentMar 03Option Exercise0.009,747084,066Mar 06 06:35 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeMar 03Option Exercise0.009,747028,488Mar 06 06:28 PM
Burbank Jeffrey HChief Executive OfficerMar 03Option Exercise0.0028,0220964,271Mar 06 06:21 PM
Turk Joseph E JrPresidentMar 01Option Exercise9.965,03950,18874,319Mar 01 06:14 PM
Burbank Jeffrey HChief Executive OfficerFeb 23Sale28.977,500217,275936,249Feb 24 05:07 PM
Burbank Jeffrey HChief Executive OfficerFeb 22Sale29.017,500217,575943,749Feb 23 08:21 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeFeb 21Option Exercise14.054,30060,41523,041Feb 23 08:14 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeFeb 21Sale29.264,300125,81818,741Feb 23 08:14 PM
Turk Joseph E JrPresidentFeb 17Option Exercise14.666,00087,96075,280Feb 21 05:21 PM
Turk Joseph E JrPresidentFeb 17Sale29.666,000177,96069,280Feb 21 05:21 PM
Swan Winifred LSVP and General CounselFeb 15Option Exercise18.4815,549287,34626,522Feb 15 04:35 PM
Swan Winifred LSVP and General CounselFeb 15Sale28.0116,049449,53210,473Feb 15 04:35 PM
Brown Robert S.President, NxStage Kidney CareFeb 14Sale28.282,44869,22917,315Feb 15 04:28 PM
Turk Joseph E JrPresidentFeb 10Option Exercise18.592,50046,47571,780Feb 13 05:07 PM
Turk Joseph E JrPresidentFeb 10Sale28.592,50071,47569,280Feb 13 05:07 PM
Turk Joseph E JrPresidentFeb 09Sale27.771,00027,77069,280Feb 13 05:07 PM
Brown Robert S.President, NxStage Kidney CareFeb 08Sale27.613,05484,32119,763Feb 08 06:07 PM
Brown Robert S.President, NxStage Kidney CareFeb 07Sale27.543,11785,84222,817Feb 07 05:07 PM
Brown Robert S.President, NxStage Kidney CareFeb 06Sale27.293,28389,59325,934Feb 06 05:21 PM
Brown Robert S.President, NxStage Kidney CareFeb 03Option Exercise14.6613,000190,58042,217Feb 06 05:21 PM
Brown Robert S.President, NxStage Kidney CareFeb 03Sale26.7713,000348,01029,217Feb 06 05:21 PM
Brown Robert S.President, NxStage Kidney CareFeb 02Option Exercise14.6613,000190,58046,962Feb 02 07:07 PM
Turk Joseph E JrPresidentFeb 02Option Exercise13.6915,669214,49385,949Feb 02 06:14 PM
Brown Robert S.President, NxStage Kidney CareFeb 02Sale26.7217,745474,14629,217Feb 02 07:07 PM
Turk Joseph E JrPresidentFeb 02Sale26.1915,669410,37170,280Feb 02 06:14 PM
MOORE CRAIG WDirectorFeb 01Option Exercise14.9915,272228,927104,511Feb 02 04:42 PM
Brown Robert S.President, NxStage Kidney CareFeb 01Option Exercise14.6613,000190,58053,564Feb 02 07:07 PM
Brown Robert S.President, NxStage Kidney CareFeb 01Sale26.6519,602522,39333,962Feb 02 07:07 PM
Brown Robert S.President, NxStage Kidney CareJan 26Option Exercise11.037,00077,21047,564Jan 26 06:49 PM
Brown Robert S.President, NxStage Kidney CareJan 26Sale26.257,000183,75040,564Jan 26 06:49 PM
Brown Robert S.President, NxStage Kidney CareJan 25Option Exercise11.0320,000220,60060,564Jan 26 06:49 PM
Brown Robert S.President, NxStage Kidney CareJan 25Sale26.1320,000522,60040,564Jan 26 06:49 PM
Brown Robert S.President, NxStage Kidney CareJan 24Option Exercise11.0315,000165,45055,564Jan 26 06:49 PM
Brown Robert S.President, NxStage Kidney CareJan 24Sale25.8615,000387,90040,564Jan 26 06:49 PM
Brown Robert S.President, NxStage Kidney CareJan 23Option Exercise11.0315,000165,45055,564Jan 23 06:07 PM
Brown Robert S.President, NxStage Kidney CareJan 23Sale25.7415,000386,10040,564Jan 23 06:07 PM
Swan Winifred LSVP and General CounselJan 20Option Exercise11.033,00033,09014,473Jan 23 06:14 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeJan 20Option Exercise14.054,30060,41523,041Jan 23 06:28 PM
Swan Winifred LSVP and General CounselJan 20Sale26.193,50091,66510,973Jan 23 06:14 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeJan 20Sale26.194,300112,61718,741Jan 23 06:28 PM
Brown Robert S.President, NxStage Kidney CareJan 19Sale27.256,615180,26240,564Jan 23 06:07 PM
Brown Robert S.President, NxStage Kidney CareJan 18Sale27.588,183225,68747,179Jan 18 06:56 PM